Featured Stories
Fisher Phillips Issues Insight: OSHA Opioid Overdose Response Guidance Urges Training, Use of Reversal Medications - What Your Business Needs To Know
ATLANTA, Georgia, Oct. 6 -- Fisher Phillips, a law firm, issued the following Insight:
* * *
New OSHA Opioid Overdose Response Guidance Urges Training, Use of Reversal Medications: What Your Business Needs To Know
Oct 5, 2026
With opioid overdoses becoming a more commonplace issue in the workplace, OSHA just produced some new guidance for employers to help prepare for these types of emergencies. A September 24 fact sheet from the agency encourages employers to offer voluntary training to staff and managers on how to identify and respond to an overdose, and to consider keeping overdose reversal
... Show Full Article
ATLANTA, Georgia, Oct. 6 -- Fisher Phillips, a law firm, issued the following Insight:
* * *
New OSHA Opioid Overdose Response Guidance Urges Training, Use of Reversal Medications: What Your Business Needs To Know
Oct 5, 2026
With opioid overdoses becoming a more commonplace issue in the workplace, OSHA just produced some new guidance for employers to help prepare for these types of emergencies. A September 24 fact sheet from the agency encourages employers to offer voluntary training to staff and managers on how to identify and respond to an overdose, and to consider keeping overdose reversalmedication onsite. While the factsheet isn't a regulation, it does suggest that OSHA views overdoses as a potential health and safety hazard that employers should be aware of. Here's everything you need to know about the guidance and steps you can take to protect your workforce, visitors, and customers.
What The Guidance Says
OSHA's guidance defines opioids as natural, semi-synthetic, and synthetic drugs, including prescription medications as well as illicit substances. The agency explains that an overdose can cause breathing to slow or stop, making a prompt emergency response critical. Managers, supervisors, and employees should understand how to respond when someone experiences a suspected overdose at work. The fact sheet also provides information on how opioid reversal medications like the FDA-approved naloxone and nalmefene work, which can temporarily reverse opioid effects while emergency responders are on the way.
OSHA's guidance identifies several potential avenues for employers seeking to obtain naloxone, including:
* Pharmacies, retail outlets, and online sellers for FDA-approved nonprescription naloxone nasal sprays.
* Wholesale pharmaceutical distributors for bulk purchases.
* Group purchasing organizations that may offer discounted pricing.
* Manufacturer programs.
* Partnerships with state or local health departments, which may offer medication at low or no cost.
What This Means For Your Business
FP's John D. Surma, a partner in the Houston office, says the guidance being issued at all serves as a bit of notice that OSHA is expecting employers to have overdose reversal drugs as part of their workplace first aid kits. OSHA regulations generally require that employers have "adequate" first aid supplies "readily available."
"Having opioid overdose reversal medications (OORMs) on hand can save lives," the notice says.
While employers may feel extremely cautious about "administering medications" to employees and potentially others in the workplace, most non-medical employers should be protected by various state "good Samaritan" laws, FP's Surma says. OSHA's guidance also emphasizes that OORMs generally are safe and effective when used as directed, work only when opioids are present in the person's system, and generally have no effect on a person who has not taken opioids.
For some industries, Travis Vance, a Regional Managing Partner FP's Charlotte office noted that having overdose reversal medications on-site could be critical for operations that rely on employees to work alone or in rural areas where emergency services may be difficult to reach or slow to respond.
"It's especially important to have overdose reversal medication on hand on construction sites, jobsites where employees may be working alone, or in areas where very few people are around," Vance said.
Other Issues to Consider
OSHA's guidance stresses that reversal medication is not a replacement for emergency medical care. Employers that opt to keep these medications in their workplace will need to implement new training protocols for their emergency response teams or managers about steps to take before or after administering these drugs.
As part of a comprehensive training program, OSHA recommends that managers, employees, and staff know:
* To call 911, even if the individual regains consciousness.
* How to recognize possible overdose symptoms, including slow or stopped breathing, blue lips, unresponsiveness, pinpoint pupils, gurgling or snoring sounds, cold or clammy skin, stupor, coma, or respiratory failure.
* How OORMs work and how to administer the particular product available at the worksite, including the possibility that a second dose may be required.
* Possible withdrawal symptoms, including shaking, sweating, nausea, or anger.
* How to place a person safely in the recovery position while awaiting emergency responders.
* Applicable Good Samaritan protections.
* The importance of treating an affected person with care, respect, and professionalism.
* Make clear that the immediate response to a suspected overdose is a medical emergency, not a disciplinary investigation.
Steps You Can Take Now
OSHA's new fact sheet is a useful reminder that workplace emergency plans should be equipped to address an opioid overdose. Stocking naloxone or another OORM is not mandated by this guidance, but OSHA outlines best practices to support the use of these medications.
1. Determine if your workplace is prepared for an overdose emergency
Review your business' emergency-action plans and first-aid procedures to ensure they clearly address a suspected overdose. It should outline who will call 911, who will retrieve emergency supplies, and how the organization will direct emergency responders to the affected person.
2. Determine whether to maintain OORMs
Deciding to carry OORMs at your worksite should account for your workforce, location, existing safety resources, and ability to store and maintain the medication properly. Organizations with multiple locations should also recognize that availability of these drugs may vary by jurisdiction. For placement, OSHA recommends visible, accessible locations, including near first-aid kits and automated external defibrillators (AEDs). Larger worksites may need multiple kits placed in different areas. Clear signs can help employees quickly locate the medication in an emergency.
3. Establish storage and supply controls
If an employer elects to stock reversal medication, OSHA recommends following the product's labeling for storage and keeping the medication away from direct light, excessive heat, and freezing temperatures. Employers should also monitor expiration dates and designate an individual - such as a safety officer - to manage inventory, storage, and restocking. Add OORM checks to the organization's existing first-aid or safety-equipment inspection schedule to easily stay in compliance.
4. Provide voluntary, product-specific training
OSHA recommends that employers consider voluntary training so employees understand both the risks of overdose and the organization's emergency-response procedures. The training should be specific to the medication and delivery method available at the worksite. Consult with your FP attorney to develop a response plan specific to your location and individual worksite risks.
* * *
Related People
John D. Surma
Partner
jsurma@fisherphillips.com
713/292-5633
* * *
Travis W. Vance
Regional Managing Partner
tvance@fisherphillips.com
704/778-4164
* * *
Original text here: https://www.fisherphillips.com/en/insights/insights/new-osha-opioid-overdose-response-guidance-urges-training-use-of-reversal-medications
[Category: BizLaw/Legal]
Carlyle to Announce Third Quarter 2026 Financial Results and Host Investor Conference Call
WASHINGTON, Oct. 6 -- Carlyle Group posted the following news release:
* * *
Carlyle to Announce Third Quarter 2026 Financial Results and Host Investor Conference Call
05 October 2026
Washington, D.C. and New York - The Carlyle Group Inc. (NASDAQ: CG) announced today that it will release financial results for the third quarter 2026 on Thursday, November 5, 2026, and host a conference call at 8:30 a.m. EST.
The conference call will be available via public webcast from the Events & Presentations section of ir.carlyle.com and a replay will also be available after the call's completion.
Chief
... Show Full Article
WASHINGTON, Oct. 6 -- Carlyle Group posted the following news release:
* * *
Carlyle to Announce Third Quarter 2026 Financial Results and Host Investor Conference Call
05 October 2026
Washington, D.C. and New York - The Carlyle Group Inc. (NASDAQ: CG) announced today that it will release financial results for the third quarter 2026 on Thursday, November 5, 2026, and host a conference call at 8:30 a.m. EST.
The conference call will be available via public webcast from the Events & Presentations section of ir.carlyle.com and a replay will also be available after the call's completion.
ChiefExecutive Officer Harvey Schwartz, Chief Financial Officer Justin Plouffe, and Head of Public Investor Relations Daniel Harris, will review the results during the call.
The earnings release will be available through all Carlyle channels, including the Earnings Releases section of ir.carlyle.com and the firm's X and LinkedIn accounts.
* * *
About Carlyle
Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit, and Carlyle AlpInvest. With $485 billion of assets under management as of June 30, 2026, Carlyle's purpose is to connect people, ideas, and capital to fuel growth for companies and performance for investors. Carlyle employs more than 2,500 people in 28 offices across four continents.
* * *
Original text here: https://www.carlyle.com/media-room/news-release-archive/carlyle-announce-third-quarter-2026-financial-results-and-host
[Category: BizFinancial Services]
UCLA Health: Lin Chang Awarded $4M NIH Grant to Study Why Ulcerative Colitis Symptoms Persist After Inflammation Subsides
LOS ANGELES, California, Oct. 6 (TNSjou) -- The UCLA Health issued the following news release:
* * *
Dr. Lin Chang awarded $4M NIH grant to study why ulcerative colitis symptoms persist after inflammation subsides
UCLA Health gastroenterologist Lin Chang and Dr. Bruce Sands of Mount Sinai were awarded a $4 million federal grant to investigate why some ulcerative colitis patients continue to experience irritable bowel syndrome-like symptoms even after inflammation has subsided.
The five-year study will be jointly conducted at UCLA and Mount Sinai, with Chang and Sands serving as co-principal
... Show Full Article
LOS ANGELES, California, Oct. 6 (TNSjou) -- The UCLA Health issued the following news release:
* * *
Dr. Lin Chang awarded $4M NIH grant to study why ulcerative colitis symptoms persist after inflammation subsides
UCLA Health gastroenterologist Lin Chang and Dr. Bruce Sands of Mount Sinai were awarded a $4 million federal grant to investigate why some ulcerative colitis patients continue to experience irritable bowel syndrome-like symptoms even after inflammation has subsided.
The five-year study will be jointly conducted at UCLA and Mount Sinai, with Chang and Sands serving as co-principalinvestigators.
Ulcerative colitis is a chronic disease that causes long-term inflammation and ulcers in the inner lining of the large intestine and rectum. Symptoms such as bloating, irregular bowel movements and cramping can resemble those of irritable bowel syndrome (IBS), a separate condition that does not cause inflammation. In about one in three (https://pmc.ncbi.nlm.nih.gov/articles/PMC4340328/) patients with ulcerative colitis, these IBS-like symptoms can persist even when inflammation is minimal or absent.
In this new study funded by the National Institutes of Health, Chang and Sands, chief of the gastroenterology division at Mount Sinai, will investigate if persistent symptoms are driven by ongoing gut inflammation or altered gut-brain signaling. To achieve this, the researchers will use a combination of brain imaging, wearable technology to measure autonomic nervous system function and will test whether non-invasive vagal nerve stimulation can improve symptoms.
The study aims to ultimately support new personalized treatment approaches for ulcerative colitis patients with little to no active inflammation with persistent IBS symptoms.
The study is set to conclude in June 2031.
* * *
Chang is the vice chief of the Vatche and Tamar Manoukian Division of Digestive Diseases at UCLA, director of the Walter and Shirley Wang Center for Integrative Digestive Health, co-director of the G. Oppenheimer Center for Neurobiology of Stress and Resilience, director of the Clinical Studies and Database Core of the Goodman-Luskin Microbiome Center and program director of the UCLA Gastroenterology Fellowship Program.
* * *
Original text here: https://www.uclahealth.org/news/release/dr-lin-chang-awarded-4m-nih-grant-study-why-ulcerative
[Category: Medical]
Ropes & Gray Represents Asimov in Strategic Collaboration With Lonza
BOSTON, Massachusetts, Oct. 6 -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Represents Asimov in Strategic Collaboration with Lonza
October 5, 2026
Ropes & Gray represented Asimov in a strategic collaboration with Lonza to advance lentiviral vector (LVV) manufacturing for emerging in vivo applications.
The deal was announced on October 2, 2026.
Asimov is building an AI-native synthetic biology platform to advance therapeutic development.
The company is backed by Andreessen Horowitz, CPP Investments, Horizons Ventures, and Fidelity Management & Research Company.
The
... Show Full Article
BOSTON, Massachusetts, Oct. 6 -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Represents Asimov in Strategic Collaboration with Lonza
October 5, 2026
Ropes & Gray represented Asimov in a strategic collaboration with Lonza to advance lentiviral vector (LVV) manufacturing for emerging in vivo applications.
The deal was announced on October 2, 2026.
Asimov is building an AI-native synthetic biology platform to advance therapeutic development.
The company is backed by Andreessen Horowitz, CPP Investments, Horizons Ventures, and Fidelity Management & Research Company.
TheRopes & Gray team was led by life sciences partner Rajarshi Banerjee and intellectual property transactions associate Zoe Dettelbach.
* * *
URL: Asimov
* * *
Original text here: https://www.ropesgray.com/en/news-and-events/news/2026/10/ropes-gray-represents-asimov-in-strategic-collaboration-with-lonza
[Category: BizLaw/Legal]
Pillsbury's London Office Continues Impressive March Up The Legal 500 UK Rankings
NEW YORK, Oct. 6 -- Pillsbury, a law firm, issued the following news release:
* * *
Pillsbury's London Office Continues Impressive March Up The Legal 500 UK Rankings
10.05.26
The 2027 edition of The Legal 500 UK highlighted the growing size and reputation of Pillsbury's London office as 11 of the firm's practices were recognized among the finest in the United Kingdom and 17 Pillsbury lawyers were individually acknowledged -- including nine who were identified as standout practitioners in the directory's commentary.
The firm's ranked practices include EU and Competition: Trade, WTO Anti-Dumping,
... Show Full Article
NEW YORK, Oct. 6 -- Pillsbury, a law firm, issued the following news release:
* * *
Pillsbury's London Office Continues Impressive March Up The Legal 500 UK Rankings
10.05.26
The 2027 edition of The Legal 500 UK highlighted the growing size and reputation of Pillsbury's London office as 11 of the firm's practices were recognized among the finest in the United Kingdom and 17 Pillsbury lawyers were individually acknowledged -- including nine who were identified as standout practitioners in the directory's commentary.
The firm's ranked practices include EU and Competition: Trade, WTO Anti-Dumping,Customs and Sanctions; International Arbitration; Transport Finance & Leasing; Emerging Markets; Technology, Media and Telecommunications (TMT); Projects, Energy and Natural Resources (Oil & Gas); Power Projects (including Electricity and Nuclear); Data Protection, Privacy & Cybersecurity; Life Sciences & Health Care; Venture Capital; and Corporate Restructuring & Insolvency.
Deborah Ruff (International Arbitration) was once again named to The Legal 500 UK Hall of Fame while Graham Tyler and Antony Single (Transport Finance & Leasing), Matthew Oresman and James Campbell (Emerging Markets), and Steven Farmer (TMT) were named "Leading Partners." Sarah Melaney (Venture Capital), Chris Knight (Transport Finance & Leasing) and Vince Zabielski (Projects) were ranked as "Next Generation Partners."
With English and U.S. law capabilities, Pillsbury's London office helps clients navigate high-stakes cross-border transactions, disputes and regulatory matters.
The team advises clients across the UK, Europe and key markets in the Middle East, Americas, Asia and Africa. To learn more about Pillsbury's London office, click here (https://www.pillsburylaw.com/en/offices/london.html).
* * *
Original text here: https://www.pillsburylaw.com/en/news-and-insights/pillsbury-moves-up-legal-500-uk-rankings.html
[Category: BizLaw/Legal]
Littler: Duty to Inform Workers in the UK of the Right to Join a Trade Union - Details Published But Timing Delayed
SAN FRANCISCO, California, Oct. 6 -- Littler, a law firm, issued the following news:
* * *
Duty to Inform Workers in the UK of the Right to Join a Trade Union: Details Published But Timing Delayed
The duty for employers to inform workers of their right to join a trade union has been delayed until January 2027.
By Philip Cameron and Emily Bodger
October 5, 2026
The UK Employment Rights Act 2025 ("ERA 2025") introduces a new obligation on employers to give workers a written statement informing them of their right to join a trade union. The stated purpose of the reform is to improve awareness
... Show Full Article
SAN FRANCISCO, California, Oct. 6 -- Littler, a law firm, issued the following news:
* * *
Duty to Inform Workers in the UK of the Right to Join a Trade Union: Details Published But Timing Delayed
The duty for employers to inform workers of their right to join a trade union has been delayed until January 2027.
By Philip Cameron and Emily Bodger
October 5, 2026
The UK Employment Rights Act 2025 ("ERA 2025") introduces a new obligation on employers to give workers a written statement informing them of their right to join a trade union. The stated purpose of the reform is to improve awarenessof workers' statutory rights, and to support workers to make an informed choice on whether they wish to join a union.
Although the ERA 2025 establishes the new duty in principle, regulations are required to prescribe the information that the statement must include, the form the statement will take and the manner in which the statement must be given. The Government launched a consultation in October 2025 seeking views to inform the content of the regulations and has now published its response setting out how it intends the duty will operate in practice.
The new duty had been expected to take effect on October 30, 2026, however implementation has been delayed and the Government has indicated that it is now anticipated to come into force on January 1, 2027.
Continue reading here (The UK Employment Rights Act 2025 ("ERA 2025") introduces a new obligation on employers to give workers a written statement informing them of their right to join a trade union. The stated purpose of the reform is to improve awareness of workers' statutory rights, and to support workers to make an informed choice on whether they wish to join a union.
Although the ERA 2025 establishes the new duty in principle, regulations are required to prescribe the information that the statement must include, the form the statement will take and the manner in which the statement must be given. The Government launched a consultation in October 2025 seeking views to inform the content of the regulations and has now published its response setting out how it intends the duty will operate in practice.
The new duty had been expected to take effect on October 30, 2026, however implementation has been delayed and the Government has indicated that it is now anticipated to come into force on January 1, 2027.
Continue reading here (https://littler.co.uk/insights/duty-to-inform-workers-of-the-right-to-join-a-trade-union-details-published-but-timing-delayed/).
* * *
Authors
Philip Cameron
Partner
London
pcameron@littler.co.uk
* * *
Emily Bodger
Knowledge Lawyer
London
ebodger@littler.co.uk
* * *
Original text here: https://www.littler.com/news-analysis/asap/duty-inform-workers-uk-right-join-trade-union-details-published-timing-delayed
[Category: BizLaw/Legal]
HPE Chosen to Deliver Intelligent Connectivity and Autonomous IT Operations at the 2027 Ryder Cup
SPRING, Texas, Oct. 6 -- Hewlett Packard Enterprise, an information technology company, issued the following news release:
* * *
HPE chosen to deliver intelligent connectivity and autonomous IT operations at the 2027 Ryder Cup
HPE will deploy a Self-Driving Network and next-generation Connected Intelligence Center to the event at Adare Manor in Ireland, enabling unified agentic IT operations
In this article
* HPE will return as a Worldwide Supplier of the 2027 Ryder Cup at Adare Manor in County Limerick, Ireland
* An HPE Self-Driving Network will provide the intelligent foundation for seamless,
... Show Full Article
SPRING, Texas, Oct. 6 -- Hewlett Packard Enterprise, an information technology company, issued the following news release:
* * *
HPE chosen to deliver intelligent connectivity and autonomous IT operations at the 2027 Ryder Cup
HPE will deploy a Self-Driving Network and next-generation Connected Intelligence Center to the event at Adare Manor in Ireland, enabling unified agentic IT operations
In this article
* HPE will return as a Worldwide Supplier of the 2027 Ryder Cup at Adare Manor in County Limerick, Ireland
* An HPE Self-Driving Network will provide the intelligent foundation for seamless,secure connectivity across the tournament
* An expanded Connected Intelligence Center will help tournament teams turn real-time data into faster, more informed action
-
London, UK - October 5, 2026 - HPE (NYSE: HPE) today announced it will return as a Worldwide Supplier of the 2027 Ryder Cup, delivering an intelligent foundation that powers the digital fan experience, autonomous IT operations and AI-driven intelligence. A seamless and secure HPE Self-Driving Network will keep fans, staff, and systems connected, and an advanced Connected Intelligence Center will provide a unified, real-time view of all tournament operations, creating an agentic enterprise that can anticipate, adapt and act.
The biennial competition which pits 12 of the top golfers from the U.S. and Europe against each other in head-to-head match play will celebrate its 100th anniversary at Adare Manor in County Limerick, Ireland, from September 17-19. Continuing a relationship which started at the 2018 Ryder Cup in Paris, HPE will help to deliver the most connected and intelligent Ryder Cup ever to ensure that the over 250,000 fans on site and over 650 million viewers around the world can follow every shot.
Creating an intelligent foundation
Underpinning Ryder Cup operations will be an HPE Self-Driving Network, using Wi-Fi 7 to provide the intelligent foundation that keeps fans, volunteers, media, staff, systems and devices securely and seamlessly connected throughout tournament week. Spanning the 230-acre golf course, grandstands, hospitality venues, media compounds and operations centers, the network will continuously monitor, adapt, and optimize user experiences in real time, helping prevent issues before they happen.
HPE will also expand the Connected Intelligence Center, first introduced at the 2025 Ryder Cup. Powered by HPE Private Cloud AI and developed by HPE Services, the enhanced operations center will securely bring together data, AI models and tools from across the tournament ecosystem in a unified operational view, helping teams monitor activity, identify emerging issues and make faster, more informed decisions. This approach will support the Ryder Cup in becoming an agentic enterprise, where intelligent autonomous IT systems can increasingly anticipate problems, adapt workflows and implement solutions to improve operations and experiences.
"The Ryder Cup sets the standard for global sporting events and its unique demands are a perfect proving ground for HPE's latest technology innovations across networking, AI and cloud," said Matt Harris, Senior Vice President & Managing Director, UK, Ireland, Middle East & Africa, HPE. "HPE is proud to return for this historic tournament and help prepare the Ryder Cup for the future with an intelligent foundation that connects people, simplifies operations and demonstrates what is possible as organizations implement autonomous, agentic IT."
"Since 2018, HPE innovation has helped us to push the technological boundaries further at each Ryder Cup and set new standards for global events," said Michael Cole, Chief Technology Officer, Ryder Cup Europe. "Our continued work with HPE will help give our teams the connectivity and intelligence needed to deliver our best ever event at Adare Manor, as well as creating a future-proofed, intelligent foundation that sets us up for future editions."
Building on a history of technology innovation
HPE's relationship with the Ryder Cup began in Paris in 2018, where it helped deliver a connected course, and continued in Rome in 2023 with an expanded technology solution supporting data-driven digital experiences. In 2025, HPE expanded its role to become a Worldwide Supplier of the Ryder Cup at Bethpage Black in New York. There, HPE introduced a Connected Intelligence Center that brought together networking, AI and operational data to deliver real-time insights and establish a foundation for future innovation.
The 2027 deployment will mark the next step in the Ryder Cup's technology evolution, moving from real-time visibility toward systems that can increasingly anticipate needs and support faster action. This progression will help the Ryder Cup operate more proactively and continue raising the standard for technology at global sporting events.
* * *
About HPE
HPE (NYSE: HPE) is a leader in essential enterprise technology, bringing together the power of AI, cloud, and networking to help organizations achieve more. As pioneers of possibility, our innovation and expertise advance the way people live and work. We empower our customers across industries to optimize operational performance, transform data into foresight, and maximize their impact. Unlock your boldest ambitions with HPE. Discover more at www.hpe.com.
* * *
Original text here: https://www.hpe.com/us/en/newsroom/press-release/2026/10/hpe-chosen-to-deliver-intelligent-connectivity-and-autonomous-it-operations-at-the-2027-ryder-cup.html
[Category: BizComputer Technology]
